{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:16:39Z","timestamp":1778883399997,"version":"3.51.4"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004348","name":"Region Stockholm","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006741","name":"Foundation Masonic Home for Children in Stockholm","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006741","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2024 \\u201303265"],"award-info":[{"award-number":["2024 \\u201303265"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2022-01392"],"award-info":[{"award-number":["2022-01392"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013495","name":"M\u00e4rta and Gunnar V Philipson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013495","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007435","name":"\u00c5ke Wiberg Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007435","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003452","name":"Innovation and Technology Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020325","name":"S\u00e4llskapet Barnav\u00e5rd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bbrep.2025.102421","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T08:29:44Z","timestamp":1767688184000},"page":"102421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Humanin improves bone health in a glucocorticoid-treated mouse model of Duchenne muscular dystrophy"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5166-0469","authenticated-orcid":false,"given":"Ther\u00e9se","family":"Cedervall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baptiste","family":"Jude","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferdinand","family":"von Walden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilly","family":"Velentza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna T.","family":"Lanner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Sejersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farasat","family":"Zaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1067-4976","authenticated-orcid":false,"given":"Lars","family":"S\u00e4vendahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrep.2025.102421_bib1","article-title":"Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy","volume":"1","author":"Bell","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bbrep.2025.102421_bib2","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00198-003-1443-y","article-title":"Bone mineral density and bone metabolism in Duchenne muscular dystrophy","volume":"14","author":"Bianchi","year":"2003","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bbrep.2025.102421_bib3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nmd.2006.01.010","article-title":"Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade","volume":"16","author":"Biggar","year":"2006","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.bbrep.2025.102421_bib4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1651-2227.1999.tb01270.x","article-title":"Short stature in Duchenne muscular dystrophy: a study of 34 patients","volume":"88","author":"Nagel","year":"1999","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.bbrep.2025.102421_bib5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejpn.2013.08.008","article-title":"Growth and psychomotor development of patients with Duchenne muscular dystrophy","volume":"18","author":"Sarrazin","year":"2014","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.bbrep.2025.102421_bib6","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.jpeds.2013.08.004","article-title":"Patterns of growth in ambulatory males with Duchenne muscular dystrophy","volume":"163","author":"West","year":"2013","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bbrep.2025.102421_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1398050","article-title":"Poor bone health in Duchenne muscular dystrophy: a multifactorial problem beyond corticosteroids and loss of ambulation","volume":"15","author":"Hurley-Novatny","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.bbrep.2025.102421_bib8","article-title":"Height development and multiple bone health indicators in children aged 2-12 years with duchenne muscular dystrophy (DMD)","volume":"20","author":"Wang","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrep.2025.102421_bib9","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.nmd.2011.02.006","article-title":"Endocrine aspects of Duchenne muscular dystrophy","volume":"21","author":"Bianchi","year":"2011","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.bbrep.2025.102421_bib10","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jpeds.2016.11.078","article-title":"Long-term outcome of interdisciplinary management of patients with Duchenne muscular dystrophy receiving daily glucocorticoid treatment","volume":"182","author":"Wong","year":"2017","journal-title":"J. Pediatr."},{"key":"10.1016\/j.bbrep.2025.102421_bib11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/01241398-200001000-00016","article-title":"Bone mineral density and fractures in boys with Duchenne muscular dystrophy","volume":"20","author":"Larson","year":"2000","journal-title":"J. Pediatr. Orthop."},{"key":"10.1016\/j.bbrep.2025.102421_bib12","article-title":"Optimizing bone health in Duchenne muscular dystrophy","volume":"2015","author":"Buckner","year":"2015","journal-title":"Internet J. Endocrinol."},{"key":"10.1016\/j.bbrep.2025.102421_bib13","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.nmd.2012.07.009","article-title":"Growth hormone treatment in boys with Duchenne muscular dystrophy and glucocorticoid-induced growth failure","volume":"22","author":"Rutter","year":"2012","journal-title":"Neuromuscul. Disord."},{"issue":"-73","key":"10.1016\/j.bbrep.2025.102421_bib14","article-title":"Growth hormone therapy for children with Duchenne muscular dystrophy and glucocorticoid induced short stature","volume":"72","author":"Lavi","year":"2023","journal-title":"Growth Hormone IGF Res."},{"key":"10.1016\/j.bbrep.2025.102421_bib15","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1210\/jc.2002-020542","article-title":"Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle","volume":"88","author":"Bramnert","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbrep.2025.102421_bib16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s40257-019-00485-z","article-title":"Drug-induced intracranial hypertension: a systematic review and critical assessment of drug-induced causes","volume":"21","author":"Tan","year":"2020","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.bbrep.2025.102421_bib17","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1542\/peds.2018-0333E","article-title":"Bone health and osteoporosis management of the patient with Duchenne muscular dystrophy","volume":"142","author":"Ward","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.bbrep.2025.102421_bib18","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000207948","article-title":"Bisphosphonates in glucocorticoid-treated patients with Duchenne muscular dystrophy: a systematic review and grading of the evidence","volume":"102","author":"Landfeldt","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.bbrep.2025.102421_bib19","doi-asserted-by":"crossref","first-page":"166","DOI":"10.4103\/ijpvm.IJPVM_33_19","article-title":"Therapeutic dimensions of bisphosphonates: a clinical update","volume":"11","author":"Vannala","year":"2020","journal-title":"Int. J. Prev. Med."},{"key":"10.1016\/j.bbrep.2025.102421_bib20","first-page":"e5222","article-title":"Zoledronic acid vs placebo in pediatric glucocorticoid-induced osteoporosis: a randomized, double-blind, phase 3 trial","volume":"106","author":"Ward","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbrep.2025.102421_bib21","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000208112","article-title":"Efficacy and safety of vamorolone over 48 weeks in boys with Duchenne muscular dystrophy: a randomized controlled trial","volume":"102","author":"Dang","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.bbrep.2025.102421_bib22","first-page":"129","article-title":"Humanin prevents undesired apoptosis of chondrocytes without interfering with the anti-inflammatory effect of dexamethasone in collagen-induced arthritis","volume":"38","author":"Celvin","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.bbrep.2025.102421_bib23","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djt459","article-title":"Protective role of humanin on bortezomib-induced bone growth impairment in anticancer treatment","volume":"106","author":"Eriksson","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbrep.2025.102421_bib24","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.1096\/fj.201801741R","article-title":"Humanin is a novel regulator of hedgehog signaling and prevents glucocorticoid-induced bone growth impairment","volume":"33","author":"Zaman","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.bbrep.2025.102421_bib25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4239\/wjd.v13.i3.213","article-title":"Humanin and diabetes mellitus: a review of in vitro and in vivo studies","volume":"13","author":"Boutari","year":"2022","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.bbrep.2025.102421_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2021.130066","article-title":"Cardio-protective role of humanin in myocardial ischemia-reperfusion","volume":"1866","author":"Gong","year":"2022","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.bbrep.2025.102421_bib27","doi-asserted-by":"crossref","first-page":"9235","DOI":"10.1523\/JNEUROSCI.21-23-09235.2001","article-title":"Detailed characterization of neuroprotection by a rescue factor humanin against various Alzheimer's disease-relevant insults","volume":"21","author":"Hashimoto","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbrep.2025.102421_bib28","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1161\/01.STR.0000242772.94277.1f","article-title":"Humanin is a novel neuroprotective agent against stroke","volume":"37","author":"Xu","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.bbrep.2025.102421_bib29","doi-asserted-by":"crossref","first-page":"11185","DOI":"10.18632\/aging.103534","article-title":"The mitochondrial derived peptide humanin is a regulator of lifespan and healthspan","volume":"12","author":"Yen","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bbrep.2025.102421_bib30","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1152\/japplphysiol.00706.2019","article-title":"Acute endurance exercise stimulates circulating levels of mitochondrial-derived peptides in humans","volume":"131","author":"von Walden","year":"2021","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.bbrep.2025.102421_bib31","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.2353\/ajpath.2010.090887","article-title":"Genetic background affects properties of satellite cells and mdx phenotypes","volume":"176","author":"Fukada","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbrep.2025.102421_bib32","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bone.2016.06.015","article-title":"Prophylactic pamidronate partially protects from glucocorticoid-induced bone loss in the mdx mouse model of Duchenne muscular dystrophy","volume":"90","author":"Yoon","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.bbrep.2025.102421_bib33","first-page":"16","article-title":"Prednisolone treatment and restricted physical activity further compromise bone of mdx mice","volume":"12","author":"Novotny","year":"2012","journal-title":"J. Musculoskelet. Neuronal Interact."},{"key":"10.1016\/j.bbrep.2025.102421_bib34","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.steroids.2008.11.009","article-title":"The challenge of continuous exogenous glucocorticoid administration in mice","volume":"74","author":"Herrmann","year":"2009","journal-title":"Steroids"},{"key":"10.1016\/j.bbrep.2025.102421_bib35","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.steroids.2016.10.008","article-title":"Continuous corticosterone delivery via the drinking water or pellet implantation: a comparative study in mice","volume":"116","author":"Gasparini","year":"2016","journal-title":"Steroids"},{"key":"10.1016\/j.bbrep.2025.102421_bib36","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/path.4231","article-title":"Selective modulation through the glucocorticoid receptor ameliorates muscle pathology in mdx mice","volume":"231","author":"Huynh","year":"2013","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbrep.2025.102421_bib37","doi-asserted-by":"crossref","first-page":"8054","DOI":"10.1038\/s41598-023-34965-4","article-title":"Pharmacological inhibition of BCL-2 with the FDA-approved drug venetoclax impairs longitudinal bone growth","volume":"13","author":"Velentza","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrep.2025.102421_bib38","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.toxlet.2013.10.020","article-title":"Dexamethasone differentially regulates Bcl-2 family proteins in human proliferative chondrocytes: role of pro-apoptotic Bid","volume":"224","author":"Zaman","year":"2014","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.bbrep.2025.102421_bib39","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1172\/JCI6730","article-title":"Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta(-\/-) mice","volume":"104","author":"Windahl","year":"1999","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrep.2025.102421_bib40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13395-018-0171-0","article-title":"MuscleJ: a high-content analysis method to study skeletal muscle with a new Fiji tool","volume":"8","author":"Mayeuf-Louchart","year":"2018","journal-title":"Skeletal Muscle"},{"key":"10.1016\/j.bbrep.2025.102421_bib41","article-title":"Docetaxel does not impair skeletal muscle force production in a murine model of cancer chemotherapy","volume":"5","author":"Chaillou","year":"2017","journal-title":"Phys. Rep."},{"key":"10.1016\/j.bbrep.2025.102421_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-55704-8","article-title":"An improved method for studying mouse diaphragm function","volume":"9","author":"Hakim","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrep.2025.102421_bib43","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.phrs.2016.02.016","article-title":"Assessment of resveratrol, apocynin and taurine on mechanical-metabolic uncoupling and oxidative stress in a mouse model of Duchenne muscular dystrophy: a comparison with The gold standard, alpha-methyl prednisolone","volume":"106","author":"Capogrosso","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbrep.2025.102421_bib44","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.nmd.2010.12.002","article-title":"Bone is functionally impaired in dystrophic mice but less so than skeletal muscle","volume":"21","author":"Novotny","year":"2011","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.bbrep.2025.102421_bib45","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/hmg\/ddv460","article-title":"Effect of genetic background on the dystrophic phenotype in mdx mice","volume":"25","author":"Coley","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrep.2025.102421_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.116248","article-title":"Cessation of ambulation results in a dramatic loss of trabecular bone density in boys with duchenne muscular dystrophy (DMD)","volume":"154","author":"Crabtree","year":"2022","journal-title":"Bone"},{"key":"10.1016\/j.bbrep.2025.102421_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9101366","article-title":"Inflammation in duchenne muscular dystrophy-exploring the role of neutrophils in muscle damage and regeneration","volume":"9","author":"Tulangekar","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbrep.2025.102421_bib48","article-title":"A novel link between chronic inflammation and humanin regulation in children","volume":"14","author":"Zhao","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.bbrep.2025.102421_bib49","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvae009","article-title":"Humanin treatment protects against venetoclax-induced bone growth retardation in Ex vivo cultured rat bones","volume":"8","author":"Velentza","year":"2024","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.bbrep.2025.102421_bib50","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.2147\/TCRM.S143317","article-title":"Fat embolism after fractures in Duchenne muscular dystrophy: an underdiagnosed complication? A systematic review","volume":"13","author":"Feder","year":"2017","journal-title":"Therapeut. Clin. Risk Manag."},{"key":"10.1016\/j.bbrep.2025.102421_bib51","doi-asserted-by":"crossref","first-page":"E587","DOI":"10.1152\/ajpendo.00219.2016","article-title":"Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice","volume":"311","author":"Piemontese","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbrep.2025.102421_bib52","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4196\/kjpp.2019.23.5.411","article-title":"Humanin suppresses receptor activator of nuclear factor-kappaB ligand-induced osteoclast differentiation via AMP-Activated protein kinase activation","volume":"23","author":"Kang","year":"2019","journal-title":"KOREAN J. PHYSIOL. PHARMACOL."},{"key":"10.1016\/j.bbrep.2025.102421_bib53","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.redox.2018.02.021","article-title":"Cardiomyocyte hypertrophy induced by endonuclease G deficiency requires reactive oxygen radicals accumulation and is inhibitable by the micropeptide humanin","volume":"16","author":"Blasco","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.bbrep.2025.102421_bib54","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.bbrc.2018.02.071","article-title":"Humanin promotes mitochondrial biogenesis in pancreatic MIN6 beta-cells","volume":"497","author":"Qin","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrep.2025.102421_bib55","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/mus.21211","article-title":"Preclinical drug trials in the mdx mouse: assessment of reliable and sensitive outcome measures","volume":"39","author":"Spurney","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.bbrep.2025.102421_bib56","doi-asserted-by":"crossref","first-page":"H1127","DOI":"10.1152\/ajpheart.00685.2017","article-title":"Chronic treatment with the mitochondrial peptide humanin prevents age-related myocardial fibrosis in mice","volume":"315","author":"Qin","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580825005084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580825005084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:47:13Z","timestamp":1778881633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580825005084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":56,"alternative-id":["S2405580825005084"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2025.102421","relation":{},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Humanin improves bone health in a glucocorticoid-treated mouse model of Duchenne muscular dystrophy","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2025.102421","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102421"}}